title: Reimbursement for outpatient biotech drugs--Part 2.
authors.affiliation: Home Intensive Care Pharmacy, San Antonio, Tex.
authors.forename: T
authors.initials: T
authors.lastname: Dasher
mesh_terms: D001709:Biotechnology / Q000191:economics*; D016527:Drug Costs; D006801:Humans; D007349:Insurance, Health, Reimbursement; D008484:Medicaid / Q000191:economics*; D006278:Medicare / Q000191:economics*; D010045:Outpatients; D011994:Recombinant Proteins / Q000191:economics / Q000627:therapeutic use; D014481:United States
chemical_list: D011994:Recombinant Proteins